Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202 - Mirhadi, Amin J.; Zhang, Qiang; Hanks, Gerald E.; Lepor, Herbert; Grignon, David J.; Peters, Christopher A.; Rosenthal, Seth A.; Zeitzer, Kenneth; Radwan, John S.; Lawton, Colleen; Parliament, Matthew B.; Reznik, Robert S.; et al. (International journal of radiation oncology, biology, physics, 2017)
Keywords: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists - therapeutic use; Antineoplastic Agents, Hormonal - therapeutic use; Combined Modality Therapy - methods; Disease-Free Survival; Drug Administration Schedule; Hematology, Oncology and Palliative Medicine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - drug therapy; Prostatic Neoplasms - mortality; Prostatic Neoplasms - radiotherapy; Radiology; Radiotherapy, Conformal; Retrospective Studies; Risk; Survival Rate; Time Factors; Treatment Outcome